trending Market Intelligence /marketintelligence/en/news-insights/trending/fxulzcoqkph0mxomnmiu7w2 content esgSubNav
In This List

Oramed Pharmaceuticals closes $18.1M common stock, warrants offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Oramed Pharmaceuticals closes $18.1M common stock, warrants offering

Oramed Pharmaceuticals Inc. said July 6 that it closed its registered direct offering with certain healthcare-focused institutional investors to raise about $18.1 million in gross proceeds.

The Israeli company offered 2,892,000 common shares and warrants to buy up to 2,892,000 common stock at a combined price of $6.25 per share and related warrant. The warrants will be exercisable six months after being issued at $7.25 per share.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.